Search details
1.
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.
Int J Cancer
; 153(5): 1026-1034, 2023 Sep 01.
Article
in English
| MEDLINE | ID: mdl-37246577
2.
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma.
Int J Cancer
; 147(11): 3152-3159, 2020 12 01.
Article
in English
| MEDLINE | ID: mdl-32391579
3.
A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma.
Pediatr Blood Cancer
; 63(1): 39-46, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26235333
4.
Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance.
Pediatr Blood Cancer
; 61(9): 1570-7, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-24687871
5.
Radiation-induced osteosarcoma of the hand: case report.
J Hand Surg Am
; 39(6): 1151-4, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24799140
6.
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
J Clin Oncol
; 42(1): 90-102, 2024 Jan 01.
Article
in English
| MEDLINE | ID: mdl-37883734
7.
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.
Genome Med
; 16(1): 28, 2024 Feb 12.
Article
in English
| MEDLINE | ID: mdl-38347552
8.
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma.
Cancer Rep (Hoboken)
; 5(11): e1616, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35355452
9.
Blood management in pediatric spinal deformity surgery: review of a 2-year experience.
Transfusion
; 51(10): 2133-41, 2011 Oct.
Article
in English
| MEDLINE | ID: mdl-21575004
10.
Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion.
Cancer Res
; 81(23): 5818-5832, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-34610968
11.
Maintenance DFMO Increases Survival in High Risk Neuroblastoma.
Sci Rep
; 8(1): 14445, 2018 09 27.
Article
in English
| MEDLINE | ID: mdl-30262852
12.
Primary thoracoscopic gross total resection of neuroblastoma.
J Laparoendosc Adv Surg Tech A
; 15(5): 470-3, 2005 Oct.
Article
in English
| MEDLINE | ID: mdl-16185118
13.
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma.
Cancer Med
; 4(6): 871-86, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25720842
14.
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.
PLoS One
; 10(5): e0127246, 2015.
Article
in English
| MEDLINE | ID: mdl-26018967
15.
Targeting receptor-activator of nuclear kappaB ligand in aneurysmal bone cysts: verification of target and therapeutic response.
Transl Res
; 164(2): 139-48, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24726460
16.
A mechanism for substrate-Induced formation of 6-hydroxyflavin mononucleotide catalyzed by C30A trimethylamine dehydrogenase.
Bioorg Med Chem Lett
; 13(22): 4129-32, 2003 Nov 17.
Article
in English
| MEDLINE | ID: mdl-14592522
17.
Focal nodular hyperplasia in oncology patients.
Pediatr Radiol
; 36(5): 464; author reply 465, 2006 May.
Article
in English
| MEDLINE | ID: mdl-16520972
Results
1 -
17
de 17
1
Next >
>>